Credit Suisse Ag Novo Cure LTD Put Options Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$58.05 - $111.31 $3.95 Million - $7.58 Million
-68,100 Reduced 62.76%
40,400 $4.5 Million
Q2 2020

Aug 12, 2020
BUY
$57.2 - $74.41 $6.03 Million - $7.84 Million
105,400 Added 3400.0%
108,500 $6.43 Million
Q4 2019

Feb 12, 2020
BUY
$68.3 - $93.8 $211,730 - $290,780
3,100 New
3,100 $261,000

Others Institutions Holding NVCR

# of Institutions
262
Shares Held
76.9M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.75B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email